Marshall Fordyce, PRESIDENT AND CEO at Vera Therapeutics, Inc. (VERA), sold 51,465 shares at $49.00 ($2.6M) on 2024-11-13, disclosed to the SEC on 2024-11-15.
Scheduled sale ($2.6M) by PRESIDENT AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.00 | 7,500 | $368K | 14.4% |
| 2 | $49.50 | 1,875 | $93K | 3.6% |
| 3 | $49.50 | 1,875 | $93K | 3.6% |
| 4 | $49.52 | 1,875 | $93K | 3.6% |
| 5 | $49.54 | 12,218 | $605K | 23.7% |
| 6 | $49.54 | 12,218 |
| $605K |
| 23.7% |
| 7 | $49.57 | 1,875 | $93K | 3.6% |
| 8 | $49.57 | 1,875 | $93K | 3.6% |
| 9 | $49.59 | 1,565 | $78K | 3.0% |
| 10 | $49.59 | 1,565 | $78K | 3.0% |
| 11 | $50.28 | 3,307 | $166K | 6.5% |
| 12 | $50.28 | 3,307 | $166K | 6.5% |
| 13 | $50.35 | 310 | $16K | 0.6% |
| 14 | $51.20 | 100 | $5K | 0.2% |
| Total | $49.57 avg | 51,465 | $2.6M | 100% |
| Filing → |
| VERA | SELL | 2026-07-09 | $2.0M | — | Filing → |
| VERA | SELL | 2026-06-24 | $702K | — | Filing → |
| VERA | SELL | 2026-05-13 | $680K | — | Filing → |